ANISOTROPINE METHYLBROMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Anisotropine Methylbromide, and what generic alternatives are available?
Anisotropine Methylbromide is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in ANISOTROPINE METHYLBROMIDE is anisotropine methylbromide. There is one drug master file entry for this compound. Additional details are available on the anisotropine methylbromide profile page.
Summary for ANISOTROPINE METHYLBROMIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 32 |
Patent Applications: | 596 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ANISOTROPINE METHYLBROMIDE at DailyMed |
US Patents and Regulatory Information for ANISOTROPINE METHYLBROMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | ANISOTROPINE METHYLBROMIDE | anisotropine methylbromide | TABLET;ORAL | 086046-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |